Literature DB >> 16038248

Report on the first meeting of the IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) consortium held at Armauer Hansen Research Institute, ALERT, Addis Ababa, Ethiopia on 24-27 October 2004.

Abraham Aseffa, Patrick Brennan, Hazel Dockrell, Tom Gillis, Rabia Hussain, Linda Oskam, Jan Hendrik Richardus.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16038248

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


× No keyword cloud information.
  6 in total

1.  Volunteerism or Labor Exploitation? Harnessing the Volunteer Spirit to Sustain AIDS Treatment Programs in Urban Ethiopia.

Authors:  Kenneth Maes
Journal:  Hum Organ       Date:  2012

2.  Leprosy elimination: not as straightforward as it seemed.

Authors:  Paul R Saunderson
Journal:  Public Health Rep       Date:  2008 Mar-Apr       Impact factor: 2.792

3.  Chemoprophylaxis in the prevention of leprosy.

Authors:  W Cairns S Smith
Journal:  BMJ       Date:  2008-04-05

4.  Geographic information systems and applied spatial statistics are efficient tools to study Hansen's disease (leprosy) and to determine areas of greater risk of disease.

Authors:  José Wilton Queiroz; Gutemberg H Dias; Maurício Lisboa Nobre; Márcia C De Sousa Dias; Sérgio F Araújo; James D Barbosa; Pedro Bezerra da Trindade-Neto; Jenefer M Blackwell; Selma M B Jeronimo
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

5.  Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.

Authors:  Lucas H Sampaio; Mariane Ma Stefani; Regiane M Oliveira; Ana Lm Sousa; Greg C Ireton; Steven G Reed; Malcolm S Duthie
Journal:  BMC Infect Dis       Date:  2011-01-26       Impact factor: 3.090

6.  Phage display and synthetic peptides as promising biotechnological tools for the serological diagnosis of leprosy.

Authors:  Silvana Maria Alban; Juliana Ferreira de Moura; Vanete Thomaz-Soccol; Samira Bührer Sékula; Larissa Magalhães Alvarenga; Marcelo Távora Mira; Carlos Chávez Olortegui; João Carlos Minozzo
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.